The Cancer Target Discovery and Development (CTD²) Network is an NCI-funded functional genomics initiative that is bridging the gap between large-scale genomic datasets and the underlying etiology of cancer development, progression, and metastasis.
On March 19, 2026, CTD2 Network investigators held a virtual, public symposium of recent advances in functional genomics and CTD2 Network research progress. During the meeting, researchers shared functional systems biology studies of tumor heterogeneity, treatment resistance in cancer, and the preclinical development of new therapeutic strategies.
Symposium Goals
- Highlight and promote CTD² Network science
- Foster interactions between CTD² Network investigators and the cancer research community
- Support CTD² program-specific opportunities and collaborations
Documents from the Symposium
Executive Summary
An executive summary of the CTD2 Network Virtual Symposium can be found in this document.
DCB Contact for the Symposium
For additional information about the symposium, please contact Dr. Claire McCarthy.